-- 加拿大太平洋堪薩斯城公司(CP.TO,CP)週一表示,該公司4月份加拿大穀物及穀物製品的運輸量創下歷史新高,上月運輸量達290萬噸(MMT),超過了2020年4月創下的此前紀錄。 該公司表示,上月30,381車皮的運輸量也刷新了4月的月紀錄,超過了2020年4月創下的紀錄。 第一季總運輸量達720萬噸,超過了2021年第一季創下的先前紀錄。該公司表示,在2025-2026作物年度的前38週,CPKC已運輸超過2190萬噸加拿大穀物及穀物製品,並補充說,這是自創紀錄的2020-2021作物年度以來加拿大穀物運輸量的最高紀錄。 「2026年伊始,加拿大穀物運輸量便創下歷史新高,今年前四個月中有三個月的運輸量也刷新了月度紀錄,這得益於我們在加拿大西部地區運輸的創紀錄穀物收成,」散裝銷售和市場營銷副總裁伊麗莎白·赫克表示。 “我們之所以能夠安全高效地交付創紀錄的穀物量,得益於我們對穀物供應鏈的持續投入,以及與遍布我們網絡的客戶緊密合作。” 該公司股票在多倫多證券交易所收盤下跌4.09美元,報113.07美元。
Related Articles
Westpac's Total Capital, CET1 Capital Up Year on Year in March Quarter
Westpac Banking (ASX:WBC, NZE:WBC) total capital and Common Equity Tier 1 (CET1) capital both increased year-over-year in the March quarter, according to a Tuesday Australian bourse filing.The bank's total capital in the three months to March came in at AU$98.54 billion, up from the AU$97.14 billion it reported in the year-ago period. Its CET1 capital for the period clocked in at AU$56.94 billion, rising from the AU$55.01 billion it reported for the March 2025 quarter.Its CET1 ratio for the March quarter was 12.4%, compared with a ratio of 12.2% in the prior-year period. It reported a liquidity coverage ratio of 132% for the quarter, compared with 135% in the same period in the previous year.
Research Alert: CFRA Raises Opinion On Shares Of Gildan Activewear To Buy From Hold
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 12-month price target of CAD98, based on 16.0x our 2026 EPS estimate and above the company's five-year average forward P/E multiple of 12.9x, reflecting our view that the company deserves an above-peer multiple. We view the recent acquisition of HanesBrands as positive and believe the company will improve Hanes' operating efficiency while capitalizing on significant synergies. GIL reported Q1 2026 results that reflect the significant impact of its HanesBrands acquisition, with revenues increasing 64% to $1.17B, $18M above estimates, while facing substantial integration-related charges. Adjusted EPS from continuing operations declined to $0.43 from $0.59, $0.08 above consensus estimates, reflecting higher share count from the acquisition and ongoing integration expenses. We now view shares more positively after a 20% decline from its 52-week high just a few months ago. Shares currently trade at 13.5x the midpoint of the company's full-year EPS guidance.
Medibank Private Reports Policyholder Growth in Nine Months to March 31, Maintains Outlook
Medibank Private (ASX:MPL) reported policyholder growth of 22,400 in its resident private health insurance business in the nine months to March 31, up 25% from the same period a year earlier, according to a Tuesday filing with the Australian bourse.The company said the resident private health insurance industry has become more competitive in recent months, with data showing consumers increasingly prioritizing value and some participants resorting to price-led customer propositions."While no new material trends have emerged in 2026, Medibank will continue to monitor utilization given historic behavior and competitor activity as we remain disciplined," it said.Medibank maintained its fiscal 2026 guidance, saying it does not expect global events and volatility to have a direct impact on its businesses.The company's main financial exposure is through its investment portfolio, which includes about AU$188 million of investments in equities, and through movements in Australia's cash rate where it flagged a roughly AU$7 million annual impact to investment income.